|
|
||||||||
Journal Article |
This new generation of SRIF analogs offer exciting opportunities to improve hormone hypersecretion in patients with GH- and TSH-secreting pituitary adenomas and possibly even in patients harboring prolactinomas and non-functioning tumors. Future development of novel analogs with improved affinity for both SSTR2 and SSTR5 may have even greater potency to suppress pituitary hormone hypersecretion and block adenoma growth.
This article has been cited by other articles:
![]() |
L. Yang, S. C. Berk, S. P. Rohrer, R. T. Mosley, L. Guo, D. J. Underwood, B. H. Arison, E. T. Birzin, E. C. Hayes, S. W. Mitra, et al. Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2 PNAS, September 1, 1998; 95(18): 10836 - 10841. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |